The Europe PEGylated Proteins Market was worth USD 172.65 million in 2016 and estimated to be growing at a CAGR of 10.20%, to reach USD 280.59 million by 2021.
- Advertising -
The market is showing great potential in the forecast period, i.e. till 2021. PEGylation is a process of attachment of covalent or non-covalent bond of PolyEthylene Glucol (PEG) polymer chains to molecules and macrostructures, like protein in case of PEGylation of proteins.
PEGylated Proteins have become very important because PEGylation of proteins help to protect protein against enzymatic dehydration and it also increases the half-life of drugs.
View Full Report @ marketdataforecast.com/market-repo…eins-market-3357/
Increasing R&D investments on pharmaceuticals and healthcare sector in this region because of high awareness of people regarding health related issues, high risk of diseases, increase in adoption of protein based drugs over non-protein based drugs and increased half-life of drugs due to PEGylation are the major driving factors of this market.
- Advertising -
On the other hand, the unpredictable accumulation of high molecular weight compounds in liver might lead to inclusion bodies with no known consequences. Furthermore, chain length of these compounds can change which might lead to unexpected clearance times in vivo.
These concerning matters are challenging this market.
Free sample of the report is available @ marketdataforecast.com/market-repo…57/request-sample
The Europe market for PEGylated Proteins is broadly categorized into Protein Type, Services, Applications, consumable and by end-users. On the basis of Protein types, it is further sub-categorized into Interferons, erythropoietin and mAbs.
On the basis of Applications, It is sub-categorized into Chronic Kidney Disease and Cancer treatment applications. On the basis of consumables, it is segmented into Reagents and PEGylation kits.
On the basis of End-Users, it is analysed under Pharmaceutical & Biotechnology Companies, CROs and academic research institutes. On the basis of End-Users, Pharmaceutical & Biotechnology Companies are the biggest sector for this market
Inquire about report @ marketdataforecast.com/market-repo…rket-3357/inquire
The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. In Europe, Germany leads the PEGylated Proteins Market, followed by France and U.K.
The market in this region is projected to grow strongly during the forecast period due to various factors such as growing awareness about health and pharmacy, financial strength to procure expensive medicines and favourable reimbursement policies.
Some of the major companies dominating the market, by their products and services include Laysan Bio, Ltd., Iris Biotech GmbH, Biomatrik Inc., Quanta BioDesign Ltd., Cealares GmbH, Creative PEGworks, Jenkem Technology USA Inc., NOF Corporation, Thermo Fisher Scientific Inc., and Merck Millipore.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: